Zdrowie i gospodarka · 06/03/2017

FDA Clears FLONASE Nasal Spray for Continued Sale

The US Food and Drug Administration (FDA) has ruled that prescription FLONASE (fluticasone propionate) Nasal Spray, 0.05 milligram, was not withdrawn from sale due to safety or effectiveness concerns, allowing the drug to remain on the market.